批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2003/02/25 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/24 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/03/21 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/09/18 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/11/21 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/02/12 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1992/09/16 |
SUPPL-20(补充) |
Approval |
Labeling |
|
|
|
1992/03/26 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1991/05/14 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/04/12 |
SUPPL-17(补充) |
Approval |
Labeling |
|
|
|
1988/06/22 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/05/05 |
SUPPL-10(补充) |
Approval |
Labeling |
|
|
|
1988/03/29 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/06/01 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/03/09 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/01/21 |
SUPPL-12(补充) |
Approval |
Labeling |
|
|
|
1985/11/01 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1985/09/10 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1985/06/14 |
SUPPL-8(补充) |
Approval |
Labeling |
|
|
|
1985/02/07 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1984/01/04 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1983/12/23 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1983/03/01 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1982/07/08 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1982/03/03 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1982/02/08 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1981/10/05 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMILORIDE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
018200 |
001 |
NDA |
MIDAMOR |
AMILORIDE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
Yes |
No |
AB |
Approved Prior to Jan 1, 1982
|
PADAGIS US |
070346 |
001 |
ANDA |
AMILORIDE HYDROCHLORIDE |
AMILORIDE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
No |
Yes |
AB |
1986/01/22
|
ENDO OPERATIONS |
079133 |
001 |
ANDA |
AMILORIDE HYDROCHLORIDE |
AMILORIDE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
No |
No |
AB |
2009/01/30
|
SIGMAPHARM LABS LLC |